USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Assignments on the Web > Patent Query

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	054122/0812			Pages:	4
		Recorded:	10/19/2020
Attorney Dkt #:	VARIOUS
Conveyance:	CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).

Total properties: 34

Patent #:	11103593	Issue Dt:	08/31/2021	Application #:	15029584	Filing Dt:	04/14/2016
Publication #:	US20160310612	Pub Dt:	10/27/2016
Title:	PEGYLATED DRUG-LINKERS FOR IMPROVED LIGAND-DRUG CONJUGATE PHARMACOKINETICS

Patent #:	NONE	Issue Dt:		Application #:	15463267	Filing Dt:	03/20/2017
Publication #:	US20170189542	Pub Dt:	07/06/2017
Title:	BETA-GLUCURONIDE-LINKER DRUG CONJUGATES

Patent #:	NONE	Issue Dt:		Application #:	15510163	Filing Dt:	03/09/2017
Publication #:	US20170247412	Pub Dt:	08/31/2017
Title:	TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES

Patent #:	RE48389	Issue Dt:	01/12/2021	Application #:	15697146	Filing Dt:	09/06/2017
Title:	ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS

Patent #:	11229708	Issue Dt:	01/25/2022	Application #:	15781244	Filing Dt:	06/04/2018
Publication #:	US20190015517	Pub Dt:	01/17/2019
Title:	CONJUGATES OF QUATERNIZED TUBULYSIN COMPOUNDS

Patent #:	NONE	Issue Dt:		Application #:	15781256	Filing Dt:	06/04/2018
Publication #:	US20180353524	Pub Dt:	12/13/2018
Title:	CANCER TREATMENT USING 2-DEOXY-2-FLUORO-L-FUCOSE IN COMBINATION WITH A CHECKPOINT INHIBITOR

Patent #:	NONE	Issue Dt:		Application #:	15890252	Filing Dt:	02/06/2018
Publication #:	US20180154011	Pub Dt:	06/07/2018
Title:	SELF-STABILIZING LINKER CONJUGATES

Patent #:	11169158	Issue Dt:	11/09/2021	Application #:	15925639	Filing Dt:	03/19/2018
Publication #:	US20180275137	Pub Dt:	09/27/2018
Title:	INTACT MASS DETERMINATION OF PROTEIN CONJUGATED AGENT COMPOUNDS

Patent #:	10894090	Issue Dt:	01/19/2021	Application #:	15943527	Filing Dt:	04/02/2018
Publication #:	US20180296693	Pub Dt:	10/18/2018
Title:	ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS

Patent #:	11027021	Issue Dt:	06/08/2021	Application #:	16085460	Filing Dt:	09/14/2018
Publication #:	US20190076549	Pub Dt:	03/14/2019
Title:	COMBINATIONS OF PBD-BASED ANTIBODY DRUG CONJUGATES WITH BCL-2 INHIBITORS

Patent #:	11844839	Issue Dt:	12/19/2023	Application #:	16088235	Filing Dt:	09/25/2018
Publication #:	US20190388546	Pub Dt:	12/26/2019
Title:	PROCESS FOR THE PREPARATION OF PEGYLATED DRUG-LINKERS AND INTERMEDIATES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	16093947	Filing Dt:	10/15/2018
Publication #:	US20190117787	Pub Dt:	04/25/2019
Title:	COMBINATIONS OF CD33 ANTIBODY DRUG CONJUGATES WITH HYPOMETHYLATING AGENTS

Patent #:	11110179	Issue Dt:	09/07/2021	Application #:	16306118	Filing Dt:	11/30/2018
Publication #:	US20190134215	Pub Dt:	05/09/2019
Title:	COMBINATION OF CD33 ANTIBODY DRUG CONJUGATES WITH CHEMOTHERAPEUTIC AGENTS

Patent #:	11191771	Issue Dt:	12/07/2021	Application #:	16308225	Filing Dt:	12/07/2018
Publication #:	US20190262354	Pub Dt:	08/29/2019
Title:	COMBINATIONS OF PBD-BASED ANTIBODY DRUG CONJUGATES WITH FLT3 INHIBITORS

Patent #:	11944689	Issue Dt:	04/02/2024	Application #:	16324198	Filing Dt:	02/08/2019
Publication #:	US20190167806	Pub Dt:	06/06/2019
Title:	DRUG CONJUGATES WITH SELF-STABILIZING LINKERS HAVING IMPROVED PHYSIOCHEMICAL PROPERTIES

Patent #:	11638762	Issue Dt:	05/02/2023	Application #:	16343140	Filing Dt:	04/18/2019
Publication #:	US20190314519	Pub Dt:	10/17/2019
Title:	TARGETED DELIVERY OF NICOTINAMIDE ADENINE DINUCLEOTIDE SALVAGE PATHWAY INHIBITORS

Patent #:	11230610	Issue Dt:	01/25/2022	Application #:	16348481	Filing Dt:	05/08/2019
Publication #:	US20190352428	Pub Dt:	11/21/2019
Title:	BIVALENT ANTIBODIES MASKED BY COILED COILS

Patent #:	NONE	Issue Dt:		Application #:	16376302	Filing Dt:	04/05/2019
Publication #:	US20190343828	Pub Dt:	11/14/2019
Title:	CAMPTOTHECIN PEPTIDE CONJUGATES

Patent #:	11319526	Issue Dt:	05/03/2022	Application #:	16414633	Filing Dt:	05/16/2019
Publication #:	US20190276796	Pub Dt:	09/12/2019
Title:	METHODS AND COMPOSITIONS FOR MAKING ANTIBODIES AND ANTIBODY DERIVATIVES WITH REDUCED CORE FUCOSYLATION

Patent #:	11033561	Issue Dt:	06/15/2021	Application #:	16452160	Filing Dt:	06/25/2019
Publication #:	US20200061091	Pub Dt:	02/27/2020
Title:	METHODS OF INHIBITION OF PROTEIN FUCOSYLATION IN VIVO USING FUCOSE ANALOGS

Patent #:	11541128	Issue Dt:	01/03/2023	Application #:	16463541	Filing Dt:	05/23/2019
Publication #:	US20200129639	Pub Dt:	04/30/2020
Title:	MULTI-DRUG ANTIBODY DRUG CONJUGATES

Patent #:	11938194	Issue Dt:	03/26/2024	Application #:	16483025	Filing Dt:	08/01/2019
Publication #:	US20220175947	Pub Dt:	06/09/2022
Title:	CYSTEINE MUTATED ANTIBODIES FOR CONJUGATION

Patent #:	11730822	Issue Dt:	08/22/2023	Application #:	16497133	Filing Dt:	09/24/2019
Publication #:	US20200222553	Pub Dt:	07/16/2020
Title:	PROCESS FOR THE PREPARATION OF GLUCURONIDE DRUG-LINKERS AND INTERMEDIATES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	16525131	Filing Dt:	07/29/2019
Publication #:	US20200062857	Pub Dt:	02/27/2020
Title:	VARIANT TARGET BINDING AGENTS AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	16573154	Filing Dt:	09/17/2019
Publication #:	US20200063180	Pub Dt:	02/27/2020
Title:	PREPARING ANTIBODIES FROM CHO CELL CULTURES FOR CONJUGATION

Patent #:	11667696	Issue Dt:	06/06/2023	Application #:	16580290	Filing Dt:	09/24/2019
Publication #:	US20200115438	Pub Dt:	04/16/2020
Title:	SELECTIVE REDUCTION OF PROTEINS

Patent #:	11931414	Issue Dt:	03/19/2024	Application #:	16608748	Filing Dt:	10/25/2019
Publication #:	US20200197524	Pub Dt:	06/25/2020
Title:	QUATERNIZED NICOTINAMIDE ADENINE DINUCLEOTIDE SALVAGE PATHWAY INHIBITOR CONJUGATES

Patent #:	11891644	Issue Dt:	02/06/2024	Application #:	16616928	Filing Dt:	11/25/2019
Publication #:	US20200149082	Pub Dt:	05/14/2020
Title:	T CELLS WITH REDUCED SURFACE FUCOSYLATION AND METHODS OF MAKING AND USING THE SAME

Patent #:	11389543	Issue Dt:	07/19/2022	Application #:	16645369	Filing Dt:	03/06/2020
Publication #:	US20200297864	Pub Dt:	09/24/2020
Title:	PROCESS FOR THE PREPARATION OF TUBULYSINS AND INTERMEDIATES THEREOF

Patent #:	11634503	Issue Dt:	04/25/2023	Application #:	16866408	Filing Dt:	05/04/2020
Publication #:	US20210095043	Pub Dt:	04/01/2021
Title:	ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 158P1D7 PROTEINS

Patent #:	NONE	Issue Dt:		Application #:	16892529	Filing Dt:	06/04/2020
Publication #:	US20200289661	Pub Dt:	09/17/2020
Title:	CD48 ANTIBODIES AND CONJUGATES THEREOF

Patent #:	11857565	Issue Dt:	01/02/2024	Application #:	16968749	Filing Dt:	08/10/2020
Publication #:	US20210008099	Pub Dt:	01/14/2021
Title:	HYDROPHOBIC AURISTATIN F COMPOUNDS AND CONJUGATES THEREOF

Patent #:	11819553	Issue Dt:	11/21/2023	Application #:	16970095	Filing Dt:	08/14/2020
Publication #:	US20210361776	Pub Dt:	11/25/2021
Title:	GLYPICAN 3 ANTIBODIES AND CONJUGATES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17026048	Filing Dt:	09/18/2020
Publication #:	US20210138077	Pub Dt:	05/13/2021
Title:	SELECTIVE DRUG RELEASE FROM INTERNALIZED CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS

Assignor

SEATTLE GENETICS, INC.

Exec Dt:

10/06/2020

Assignee

SEAGEN INC.

21823 30TH DRIVE SE

BOTHELL, WASHINGTON 98021

Correspondence name and address
	SEAGEN INC.
	21823 30TH DRIVE SE
	BOTHELL, WA 98021

Search Results as of: 06/17/2024 01:14 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6